End-stage knee osteoarthritis is often used as a surgery label, not a disease stage
The phrase end-stage knee osteoarthritis carries a sense of finality, but clinical use of the term is far less precise than the wording suggests. In a scoping and narrative review published in Osteoarthritis and Cartilage Open, Egerton and Campbell examined how the term appears across medical literature and relevant websites, then compared those usages with contemporary understanding of knee osteoarthritis. The result was a definition problem with real clinical consequences: in practice, “end-stage” was used almost universally to mean the patient was eligible for surgery.
That shorthand collapses several different clinical ideas into one phrase. A radiograph with marked joint damage, a patient with severe pain and loss of function, and a person who has crossed a threshold toward arthroplasty are not identical scenarios, yet the label often treats them as if they were. In an illness as variable as knee osteoarthritis, the label can obscure more than it clarifies.
Four competing ways clinicians and websites defined the term
Medline and 16 relevant websites were searched for the term “end-stage (knee) osteoarthritis,” and 130 resources were identified. From those, the authors extracted 20 distinct definitions and grouped them into four themes.
One group used a radiographic evidence approach, relying on joint imaging to define disease severity. Another used a clinical criteria or symptom burden approach, bringing pain, function, and lived experience into the definition. A third treated the phrase as a synonym for surgical indication, effectively making “end-stage” mean that surgery is needed. The fourth combined radiographic and clinical variables into an integrated radiographic and clinical algorithm, using both imaging and symptoms in a decision rule.
The spread is wider than a semantic dispute. It changes who gets counted in studies, who gets labeled in clinic, and how patients interpret their own prognosis. A patient can have severe structural change and still report meaningful improvement with non-surgical care; another can have high symptom burden without a clear surgical pathway. The term does not reliably separate those realities.
Imaging alone does not capture the full burden of knee osteoarthritis
Radiographic severity remains deeply embedded in musculoskeletal practice, but knee osteoarthritis does not behave like a purely imaging-defined condition. Joint space narrowing, osteophytes, and other structural findings help describe the disease, yet pain and disability do not always track neatly with the x-ray. The review’s critique is built on that mismatch.
A person may meet a radiographic threshold that sounds terminal and still respond to exercise therapy, weight management, analgesia, or other non-surgical measures. Another may have disabling pain, poor sleep, and difficulty walking despite less dramatic imaging. In both cases, the phrase “end-stage” can push attention toward arthroplasty before the clinical picture is fully considered.
This matters because total knee arthroplasty is frequently described as the “gold standard” treatment in the reviewed material. Surgical replacement can be appropriate and life-changing for selected patients, but “gold standard” is not the same thing as “inevitable next step.” The review places that assumption under pressure by showing how often the term is used as an access code to surgery rather than a carefully defined diagnostic state.
Patients can still improve after an end-stage label
A sharp line does not exist between “too far gone” and “treatable.” Pain and function can improve in people described as having end-stage osteoarthritis, and non-surgical treatment options remain available. That is the central clinical tension in the review.
The biology of osteoarthritis helps explain why. Symptoms arise from a combination of mechanical loading, synovial inflammation, muscle weakness, altered movement patterns, pain sensitization, and structural change. Even when cartilage loss is advanced, interventions that reduce load, improve strength, and address pain processing can still alter the patient’s day-to-day function. Labeling a knee as “end-stage” can create the impression that these pathways no longer matter.
One sentence in the review captures the problem with unusual clarity: “end-stage” is not necessarily the “end.”
Surgical threshold is a more precise clinical phrase
The authors recommend replacing vague language in clinical practice with terminology that better reflects decision-making. Their preferred example is surgical threshold, a phrase that signals when a person becomes eligible to consider surgery without implying that the disease has reached some absolute biological terminus.
That distinction is useful at the bedside. Surgical eligibility depends on symptom burden, function, imaging, comorbidity, patient goals, and the adequacy of non-surgical care. It is a decision point, not a single disease stage. Using “surgical threshold” keeps the conversation focused on timing, shared decision-making, and the patient’s broader clinical context.
This also reduces the chance that language will overstate certainty. A person may be a reasonable arthroplasty candidate while still having viable non-operative options. Another may have severe symptoms but be a poor surgical candidate for medical or personal reasons. A single label cannot capture both situations without losing meaning.
Research eligibility needs clearer constructs than a catch-all label
For research, the authors recommend using specific tools that measure clearly defined constructs. That approach is more rigorous than relying on a label that can mean radiographic severity in one study, symptom burden in another, and surgical candidacy in a third.
Standardizing terminology would make study populations more comparable. It would also make it easier to interpret outcomes across trials and observational cohorts, especially when comparing patients with structural severity, functional limitation, and treatment preference. Without that clarity, the phrase “end-stage” risks becoming an administrative convenience rather than a valid scientific category.
The review does not argue against surgery in advanced osteoarthritis. It argues against imprecision. Patients deserve a description that matches their actual disease experience, and investigators need definitions that can withstand comparison. In this setting, a term that sounds definitive may be the least exact part of the chart.
Language now carries part of the treatment burden
The review leaves a practical message for clinicians, researchers, and guideline writers. When a term is used to mean several different things at once, it can distort care before a treatment decision is even made. Knee osteoarthritis remains multidimensional, variable, and responsive to more than one pathway of care.
What the phrase should not do is prematurely close the case. In everyday practice, the better question is not whether a knee is “end-stage,” but whether the patient has reached a point where surgery should be considered, whether non-surgical therapy has been fully used, and how symptoms, function, and imaging align in that individual. The review argues for that more exact conversation, and for terminology that does not turn a clinical threshold into a false ending.